Cajolo, Ritchel B.
HRN: 27-34-72 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2025
CEFUROXIME 1.5GM (VIAL)
07/07/2025
07/08/2025
IVT
1.5g
PTOR
For Elective USO
Checking Initial Appropriateness
07/08/2025
CEFUROXIME 1.5GM (VIAL)
07/08/2025
07/14/2025
IV
1.5g
Q8
Pelvic Lap
Waiting Final Action
07/08/2025
CEFUROXIME 500MG (TAB)
07/09/2025
07/15/2025
PO
500mg
Bid
Pelvic Lap
Checking Initial Appropriateness
07/09/2025
MUPIROCIN 2%, 15G (TUBE)
07/09/2025
07/15/2025
TOPICAL
Apply Liberally
OD
S/P USO
Checking Initial Appropriateness